You May be Entitled to Significant Compensation Talc and ovarian cancer. Johnson & Johnson powders were proven to contain asbestos (a cancer causing agent) and the company failed to notify users of the cancer risk. $2 BILLION has already been awarded to claims. Free To File! No Fees Unless A Settlement Is Awarded!

J&J’s proposed talc settlement would pay $440 million US state AGs. Talc And Ovarian Cancer .

Johnson & Johnson (JNJ.N) has set aside $400 million to address U.S. state consumer protection actions as part of its larger $8.9 billion effort to settle allegations that its Baby Powder and other talc-based product causes cancer. Talc and ovarian cancer.

J&J company subsidiary LTL Management filed a bankruptcy plan in New Jersey late on Monday that outlines how the firm will pay various types of cancer sufferers in bankruptcy settlement. Talc and ovarian cancer. J&J has claimed that its products containing talc are safe and don’t cause cancer. The company is trying for another time to settle more than 38,000 lawsuits in bankruptcy and stop new cases from arising in the future.
The bankruptcy plan of LTL would pay $400 million to an additional trust to settle claims filed from state attorney generals claiming that J&J violated state unfair business practices and consumer protection laws by misinforming consumers about the dangers of its talc products.

Many states had initiated consumer protection cases against J&J prior to LTL’s bankruptcy filing prevented those investigations from progressing in 2021. Talc and ovarian cancer. New Mexico and Mississippi had already filed suits in the past against Johnson & Johnson before then as well as the states of Arizona, Maryland, North Carolina, Texas and Washington had issued civil investigative requests or subpoenas according to court papers.

New Mexico and Mississippi have filed a petition to end LTL’s bankruptcy along with cancer sufferers and the U.S. Justice Department’s bankruptcy watchdog. have claimed that a lucrative company such as J&J is not eligible for bankruptcy protections intended for those struggling with debt.
LTL’s first attempt at resolving the bankruptcy cases was rejected after the same arguments. In the end, a U.S. appellate court ruled the LTL wasn’t in “financial trouble” and ineligible for bankruptcy protection. Talc and ovarian cancer. LTL made a new bankruptcy application within two hours of the dismissal, saying that the second bankruptcy was different because there was less money available and had more support for a settlement.

New Mexico and Mississippi said in their motion for dismissal that LTL’s latest bankruptcy violation of the law enforcement powers of the state by seeking to unilaterally limit the liability of the company for state consumer protection measures.

Talc And Ovarian Cancer

LTL’s new filings also included additional details about how the company plans to evaluate and pay claims for cancer if the bankruptcy plan is approved.

The highest payments under the settlement would be $500,000 for those diagnosed with mesothelioma terminal prior to age 45. Talc and ovarian cancer. The second payment would be $260,000 for patients diagnosed with advanced ovarian cancer before age 45.

The proposed settlement applies discounts depending on the nature and severity of the cancer, the person’s years of age, their history of usage of talc and other variables. Talc and ovarian cancer. For example someone who regularly used the talc product on a regular basis, had the family history of ovarian cancer and was diagnosed the stage 2 ovarian cancer by age 55 might qualify to receive a payment of $21,125 under the program.

Judge ordains J&J, talc opponents to participate in settlement talks.

Following another round of hearings in Johnson & Johnson’s effort to use a Texas Two-Step bankruptcy strategy for talc litigation and federal bankruptcy judge Michael Kaplan has ordered the company and those opposed to the plan to hold settlement talks, Bloomberg reports.

With its second bankruptcy attempt for LTL Management, a subsidiary set up by J&J to hold the claims–the company proposed a settlement of $8.9 billion. Talc and ovarian cancer. While a group of law firms representing plaintiffs support the offer, another group is against the settlement.

This week, the opposition group, which is known as the Official Committee of Talc Claimants and urging the bankruptcy court to dismiss the case asserting that LTL is not a factor to be in financial trouble.

“The filing is an incredibly legal and ineffective attempt by a few of law firms to try to stop claimants from deciding on the resolution plan, a plan that the overwhelming majority of claimants support,” J&J’s litigation chief Erik Haas, said in a statement. Talc and ovarian cancer. “The law firms that are behind these filings have interests in finance that clash with, diverge from, and infringe on the rights of their clients. We’ll submit a response an appeal to the appellate court.”

Talc and ovarian cancer. Clay Thompson, a lawyer for MRHFM that is home to more than patients with mesothelioma who have sued J&J claimed that the company’s second bankruptcy try will fail.

“J&J issue press releases about how great the plan is but simultaneously requesting that details of the plan, such as what each sick person will receive,” Thompson said in the statement. “What do J&J have to cover up?”

Kaplan has directed the parties to create a strategy for reorganization, under the supervision by two mediators.

In February 2022, Kaplan affirmed the ability of J&J’s recourse to Chapter 11 to hasten a settlement that would free J&J from the tens of thousands of claims related to its talcum-based products.

But in January of this year, a federal appeals court overturned the verdict, ruling that the firm could not be considered to be in “financial financial distress.”

When J&J’s attempt to challenge the U.S. Supreme Court was dismissed in April, J&J was granted a second petition for bankruptcy roughly two hours after. In response to that move, Kaplan froze the lawsuits for 60 days in order to determine whether to allow an additional bankruptcy.

J&J’s unstoppable profit machine sputters after $6.9B the talc litigation cost.

In the Two Chapter 11 attempts, J&J has been able to buy 19 months in which cases were put in limbo. Talc and ovarian cancer. J&J wants the claimants to accept their settlement. J&J would need 75% approval for the deal to go through.

Alongside the group of talc lawyers that criticized the bankruptcy of the company in the U.S. Trustee, the U.S. Trustee which is a division belonging to the U.S. Department of Justice has also filed motions to dismiss the second bankruptcy case of LTL.

In a letter filed this week, U.S. trustee Andrew R. Vara wrote that the bankruptcy courts are “open to honest but unfortunate debtors.” These doors “are not accessible to those that do not have a legitimate goal or who seek to abuse the bankruptcy process to delay or hinder their creditors.” Vara continued.

For its part, J&J maintains there is no conclusive evidence that its talc products, including the famous baby powder, can cause cancer. J&J has been taking the products of the market first in North America in 2020–and the rest of the world next year.

J&J wants to avoid the costly business of going to court. It has won most of the cases that were decided at trial, but some losses have been very punishing.
A highly publicized trial in Missouri led to an $4.7 billion verdict against the drugmaker, which was later reduced to $2.1 billion following appeals.

Johnson & Johnson faces high-stakes hearing over ‘Texas Two Step’ talc strategy: report
In all, J&J has lost nine talc trials that are either in appeal or resolved. Of the 41 trials, 32 ended with an outcome for J&J either through a mistrial or plaintiff verdict that was overturned upon appeal. Talc and ovarian cancer. The company also in 2020 sought to settle around 1,000 cases for $100 million, Bloomberg reported at the time.

Talcum Baby Powder Ovarian Cancer Lawsuit – Talc And Ovarian Cancer

Our lawyers are handling the baby powder litigation in all 50 states. The lawsuits involving talcum powder for Johnson & Johnson have been ongoing for years. Talc and ovarian cancer. The lawsuits allege that prolonged use of talcum powder (or “talc”), the active ingredient in products such as Baby Powder as well as Shower to Shower as well as other products, may cause cancer of the ovary in certain women.

This page offers an J&J talc power litigation update and discusses how the upcoming bankruptcy ruling affects the final settlement amount in these Ovarian Cancer lawsuits.

Has the deadline passed for you to bring a talcum lawsuit? Many people who think the time limit has expired to sue Johnson & Johnson are wrong. Call us at 800-553-882 or get a free and quick review of your case online.

Johnson and Johnson Talcum Powder Lawsuit Update 2023 – Talc And Ovarian Cancer

June 2, 2023 Update: During the trial for asbestos-containing talc which took place in California yesterday, some technical issues halted the opening statements of the defense attorneys. Talc and ovarian cancer. Jurors who were watching at home via Zoom but did not hear Johnson & Johnson’s lawyer expressing doubts about the 70s research asserting the presence of asbestos in their product, but the proceedings abruptly ended.

Meanwhile, the plaintiff could introduce the first of their witnesses, Arthur Langer. Langer stated that the presence of other minerals in talc is inevitable. He also testified that his team informed J&J in the year 1971 of the presence of chrysotile asbestos within the talc produced by the company, although at lower than 0.1 percent. He also found more asbestos in the year 1976.

June 1st, 2023 Update Talc and ovarian cancer. A trial for the first time since J&J made the decision to split its Talc segment and file for bankruptcy is an important point for the ongoing lawsuit saga. The trial began on Tuesday in the tragic case of a young, 24-year-old plaintiff who was diagnosed with an extremely rare and aggressive form of mesothelioma last year, an illness that lawyers on both sides acknowledge is a tragedy of a different kind.

Opening statements revealed huge differences between the sides’ narrative. The attorney representing the plaintiff aimed his ire against Johnson & Johnson, alleging that the company employed deceitful strategies in its research practices as well as throughout the litigation procedure. The attorney claims that, according to, Johnson & Johnson tried to alter the definition of asbestos despite internal documents dating back to between 1978 and 1994 that showed fibers discovered in the tissues of the plaintiff are part of.

Johnson &J’s highly uncertain $8.9 billion settlement deal hangs in the balance with the development of the trial. Despite the unique nature of this mesothelioma case and its distinctive issues in comparison to other lawsuits involving talcum powder ruling in favor of the plaintiff could result in a serious setback to J&J’s hopes of broad acceptance of their proposed settlement among plaintiffs.

May 31 2023 Update: Johnson & Johnson’s bankrupt talc unit strongly defended it’s two-time Chapter 11 filing in the facing challenges from injured talc claimants. In a written objection to the New Jersey bankruptcy court, the company argued that the filing was distinct from the prior filing. It emphasized the unprecedented commitment of $8.9 billion in settlement from J&J the largest settlement ever in the history of a mass tort bankruptcy. Talc and ovarian cancer. It was not mentioned how the amount of the settlement signifies that it’s a fair settlement. J&J also claimed that it received support from a variety of plaintiffs’ law firms representing over 60,000 claimants. This is not easy to confirm but it’s likely to be false.

May 24 2023 Update: In the wake of Johnson &J Johnson’s bankruptcy filing, the first trial concerning its cosmetic talc products allegedly comprised of asbestos is set to start jury selection Monday in California in Alameda County Superior Court, a historically good jurisdiction for plaintiffs. The plaintiff claims that his mesothelioma was triggered by asbestos exposure resulting from J&J’s products and the company does not deny. The trial also involves six retailers accused of selling talc products.

May 22nd, 2023 Update: Lawyers involved in the second J&J talc bankruptcy are fighting over who should be appointed to the post of the claims representative in the future, an important role essential to the resolution of the Talc claims. Talc and ovarian cancer. Randi Ellis, a lawyer who regularly appears in MDLs throughout the United States, was appointed as the claims representative in the previous bankruptcy. J&J’s defense team wants Ellis to be appointed to this position in the future, however lawyers representing the talc plaintiffs have raised objections because Ellis has a conflict of interest that would prevent her from being appointed to that post in the future. This conflict is rooted in the issue that Ellis was involved in the creation of the hotly contesting second bankruptcy, which raises concerns regarding her capacity to remain neutral. It’s true that this bankruptcy is likely to get dismissed anyway.

May 17, 2023 Update: The fake company J&J created to settle the talc litigation bankruptcy disclosed to an New Jersey bankruptcy court that they have allocated $400 million as a settlement for claims brought by states accusing J&J of misleading marketing for its talc product. Talc and ovarian cancer. It’s a $8.5 billion settlement for cancer sufferers. It’s difficult to imagine the scenario in which J&J can get the baby powder settlements with these numbers. Although J&J’s $8.5 billion offer may seem like a huge sum at first, it does not look very appealing after you calculate the figures. The proposed settlement based on our rough calculations, would not be able to pay victims more than an average settlement $100,000 per instance. That is not enough.

May 15 2023, Update J&J is potentially facing a suit from an advocacy group that represents cancer patients. Talc and ovarian cancer. The group claims that J&J deliberately retracted an $61.5 billion contract for funding with its subsidiary, LTL Management LLC, to simulate financial distress and validate the unit’s Chapter 11 bankruptcy filing. The group argues that this act is equivalent to a fraudulent transfer of rights of compensation for victims. They plan to explore J&J’s actions following of the decision to dismiss LTL’s first bankruptcy case.

May 10 2023 Update: Next week this week, the U.S. Bankruptcy Court in New Jersey will hear oral arguments on a petition to dismiss the second bankruptcy application from J&J subsidiaries LTL Management. In the meantime the bankruptcy has issued an order requiring both sides to take part in a new settlement negotiation hoping that an international settlement agreement can be reached.

May 5 2023 Update: The talc provider Whittaker, Clark & Daniels filed for Chapter 11 bankruptcy due to several lawsuits alleging that its talc products cause cancer due to asbestos exposure. Talc and ovarian cancer. More than 2700 people have filed lawsuits against the company, and it was spending $1 million a month on legal defense. The company’s latest $29 million settlement at the Supreme Court of South Carolina forced it to seek bankruptcy protection, arguing for an equitable distribution of assets between the claimants of talc instead of being taken over in the hands of the receiver. Other talc suppliers have also been forced to file for bankruptcy as a result of lawsuits.

May 4 2023 Update U.S. Court of Bankruptcy Michael Kaplan has directed Johnson & Johnson to relaunch negotiations with lawyers who have rejected the company’s $8.9 billion deal. In Trenton, New Jersey yesterday, the parties appeared before a judge to discuss the next steps for another bankruptcy proceeding. Judge Kaplan pushed more settlement talks.

This is the solution to settle these claims for J&J. A baby powder settlement could be completed. Talc and ovarian cancer. But it will require more money, more billions of dollars of Johnson & Johnson.

Lawyers are split on whether or not to accept the plan and not every client sees the issue in the same manner their lawyer sees it. A second bankruptcy proceeding is expected to go nowhere and Judge Kaplan has set a date for a hearing in June to determine if she will dismiss the bankruptcy for the second time.

May 3 2023 Update A group of cancer victims who are suing Johnson & Johnson (J&J) requested that they request that the Third Circuit halt the bankruptcy filed by J&J subsidiary LTL Management, claiming it attempts to block litigation regarding talc-related products. The group representing claimants for talc made a motion Tuesday requesting to the Third Circuit to consider their case and then send it back to a lower court, with instructions for dismissing the bankruptcy. Talc and ovarian cancer. The committee also requested that the stopped tort litigation against J&J allow the litigation to continue.
LTL has filed for Chapter 11 protection once again following the bankruptcy filing it made earlier was denied by the Third Circuit earlier this year with an $8.9 billion deal. The committee believes that the recent ruling which allowed LTL’s third Chapter 11 to continue, while also halting trials against J&J should be subject to immediate Third Circuit review. The US Trustee has also requested it be requested that the New Jersey bankruptcy court dismiss the LTL bankruptcy case. J&J’s global vice president of litigation, Erik Haas, was quoted by Bloomberg as saying that J&J intends to file a reply to the appeals court declaring the filing an “desperate and legally flawed move” by a small number of law firms that have conflicting financial interests.
May 1, 2023 Update: One common question that people ask is how plaintiffs and their attorneys turn on $8.9 billion. Of course, it’s quite a sum. There are a lot of victims. Talc and ovarian cancer. And these are really good cases for plaintiffs. We were reminded of this recently when two talc cases resulted in big verdicts for plaintiffs. In February mesothelioma, a talcum-based powder trial in Oregon resulted in an award worth $18.1 million. The following month, a second talc mesothelioma case went to trials on the other side of South Carolina and resulted in a verdict of $29million in favor of plaintiff. Both cases were defended by Whittaker, Clark & Daniels Inc. One of the most prominent suppliers of talc within the U.S.
April 30th, 2023 Update: When J&J first tried to bring the talcum powder lawsuit into bankruptcy, it was met with an offer to put aside $2 billion to settle the case. The amount was absurdly low. There was no one among the talc victims who supported the proposal. This time around, however, J&J has increased the offer to $8.9 in the event that the talc victims agree to a bankruptcy settlement and they also have the backing of a significant part of the talc-related plaintiffs and their attorneys. Talc and ovarian cancer. But 75% of the plaintiffs who are a talc, which is necessary for bankruptcy plan approval is not an easy task due to the sheer number of lawyers with large inventory of baby powder lawsuits opposed in favor of the deal.

What can be done to end the impasse? More billions.
April 25 2023 Update: Talc cancer claimants have requested a judge to dismiss their Chapter 11 case filed by LTL Management LLC, a ridiculously made-up Johnson & Johnson subsidiary, saying the company is not financially strained. LTL has filed for Chapter 11 to settle tens of thousands of claims that J&J’s baby products caused cancer. Talc and ovarian cancer. LTL was denied Chapter 11 in January. 3rd Circuit dismissed its first Chapter 11 case in January in a ruling that said the company was not eligible for bankruptcy relief because it failed to show financial distress.

The plaintiffs argue that LTL’s 2nd Chapter 11 case is an overreach of the bankruptcy system and that the case is being handled in bad faith. J&J asserts that the bankruptcy settlement is backed by “significant backing” from the firms that represent around 60,000 claimants. It’s safe to say that the plaintiffs’ attorneys and victims ‘ lawyers are divided on the $8.9 billion settlement offer.

April 21st, 2023 Update: A bankruptcy judge ruled in favor of Johnson & Johnson must face new lawsuits alleging that it offered a baby powder with a contaminant that caused cancer. Although trials for talc lawsuits are paused for a minimum of 60 days however, new lawsuits may be filed and lawyers may begin to prepare their cases. Talc and ovarian cancer. Judges expressed doubt about J&J’s attempt to relaunch its strategy in the second bankruptcy case.

April 13th 2023 Update: most important story is that there’s an $8.9 billion over the next 25 years settlement offer. Lawyers representing cancer patients involved in MDL class action MDL Class Action have pledged to fight the settlement with Talc claimants. Why? They argue that it’s not enough for more than 70,000 cancer victims. Talc and ovarian cancer. These lawyers believe that J&J should negotiate a bigger settlement or settle individual claims if the most recent bankruptcy is dismissed.

But there is another lawyer group that isn’t part of the top leadership in the class action. These lawyers have collectively amassed hundreds of thousands of cases. They want to settle the case now for what many argue is less than these victims deserve. The argument they make is twofold. First, they argue that the settlement, which is about the equivalent of $100,000 per plaintiff is fair.

This argument isn’t easy to prove. The second argument is more teeth: victims can now not wait and they want to get their money right now.

April 12, 2023 Update: People are seeking out how J&J is able to file for bankruptcy once more. The answer is complicated and convoluted. Let’s try to clarify it simply.
Johnson & Johnson asserts that bankruptcy is the only means to address both present and future talc lawsuits conclusively. In other words, it believes it can pay less in the event of an element of bankruptcy that puts pressure to negotiate a settlement. Talc and ovarian cancer. Going back to the 400-year span of American history, the company believes that bankruptcy is beneficial to all parties as it distributes settlement payments more equitably and effectively than trial courts, where litigants are awarded significant payouts, while others are left with nothing.

The main thrust in the 3rd Circuit decision was this is not a matter of the profit-making company that has an entity to assume the legal burden and declare bankruptcy Congress had in mind when it came to drafting the Bankruptcy Code. But it also said that the entity was financially difficulty due to the fact that J&J assured it of unlimited funding.
Thus, J&J did not hesitate to take advantage of the funding unlimited part of the agreement and didn’t promise to provide unlimited funding for the litigation. The company says that its new financing agreements with its subsidiary will address concerns of the appellate court, while providing funds for claims. As if offering victims lower amounts of money would resolve the problem at hand.

Attorneys representing cancer patients who oppose the deal counter this argument by saying that it is the legal argument. Talc and ovarian cancer. They counter with legal absurdity: J&J fraudulently transferred $50 billion in assets away from LTL Management to circumvent the appeals court’s earlier decision. Hyperbole is not exempt attorneys representing the victims claim it the largest “fraudulent transaction that has occurred in United States history.”

In spite of the legal jargon, J&J does not really think that the bankruptcy will endure. But it is a way to try and push the $8.9 billion settlement to keep the pressure on plaintiffs.

April 10 2023 Update: Bloomberg has an interesting report on a brand new law within New Jersey that is shedding new light on the funding of litigation in the baby powder class action lawsuit. Funders of litigation Virage Capital Management and TRGP Capital invested in hundreds of lawsuits in the case of Johnson & Johnson (J&J) on behalf of talc products. They exchanged for a portion of any profits. J&J is now willing an offer of $8.9 billion in settlements for all lawsuits.

The involvement of funders is made public because of an New Jersey court rule requiring the disclosure of certain information about outside funding backers. The law is designed to respond to the increasing calls for the regulation of litigation funders. J&J has to deal with more than 60,000 lawsuits when you include state and federal infant powder litigation. Third-party funding of mass tort cases has pros and pros and. However, there is no doubt that we are witnessing how third-party funding could level the playing field between individuals and big companies in court.

April 4, 2023 Update: It is enjoyable to see the worm turn in this lawsuit. J&J was hit again this week when it was found that the Third Circuit denied J&J’s request to continue the automatic stay as J&J appeals an appeal at the U.S. Supreme Court. This automatic stay froze thousands of talcum powder cases and stopped new lawsuits from arising ever since J&J initiated the controversial effort to spin the talc liability off into a bankrupt company over one year earlier. Talc and ovarian cancer. After it was decided that the 3rd Circuit ruled that this bankruptcy was invalid a few months ago, the stay was removed. J&J was hoping to have it stayed in place until the SCOTUS appeal. But, no.
April 1st, 2023 Update Johnson & Johnson announced it will appeal its 3rd Circuit bankruptcy loss to the U.S. Supreme Court last week. The odds that of the Supreme Court is willing even to hear the appeal? Low.
March 16th 2023 Update: With the bankruptcy stay now officially lifted, the first new cases have been filed and transferred into the class action for talcum powder MDL in over one year. Seven new talc lawsuits have been included in the MDL in the past month which brings the total number of cases in the pending process up to 37,522.

February 25, 2023 Update: A Congressmen from Tennessee is now demanding that The U.S. Government Accountability Office (GAO) begin an investigation into the cost J&J talc products have cost the government in the many years.
in a letter to the GAO, Rep. Steven Cohen (D-Ten.) accused J&J of ignoring the risks of its talc-based products for decades while tax dollars were spent on treating people who suffered injuries from exposure to the product. The suit comes just a few days after J&J’s loss to the 3rd Circuit Court of Appeals.

Talc and ovarian cancer. J&J needs to start making reasonable settlements to victims, in order the process of putting all this behind it. This is a blemish on one of the world’s greatest businesses.

February 14 2023 Update: During a hearing today at the hearing in New Jersey, U.S. Bankruptcy Judge Michael Kaplan announced his intention to follow the 3rd U.S. Circuit Court of Appeals ruling to dismiss the bankruptcy case.